Liquidia Corporation (NASDAQ: LQDA) stock jumped 1.87% on Wednesday to $4.89 against a previous-day closing price of $4.80. With 0.25 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.2 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.9700 whereas the lowest price it dropped to was $4.7900. The 52-week range on LQDA shows that it touched its highest point at $8.79 and its lowest point at $3.26 during that stretch. It currently has a 1-year price target of $13.14. Beta for the stock currently stands at 0.23.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LQDA was up-trending over the past week, with a rise of 2.52%, but this was down by -0.81% over a month. Three-month performance dropped to -33.38% while six-month performance rose 33.97%. The stock gained 28.01% in the past year, while it has gained 0.41% so far this year. A look at the trailing 12-month EPS for LQDA yields -0.82 with Next year EPS estimates of -0.71. For the next quarter, that number is -0.15. This implies an EPS growth rate of 60.50% for this year and 2.70% for next year.
Float and Shares Shorts:
At present, 64.46 million LQDA shares are outstanding with a float of 55.26 million shares on hand for trading. On Oct 13, 2022, short shares totaled 3.22 million, which was 5.01% higher than short shares on Sep 14, 2022. In addition to Dr. Roger A. Jeffs Ph.D. as the firm’s CEO & Director, Mr. Robert A. Lippe serves as its Chief Operations Officer.
Through their ownership of 51.10% of LQDA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 50.72% of LQDA, in contrast to 38.36% held by mutual funds. Shares owned by individuals account for 11.00%. As the largest shareholder in LQDA with 16.54% of the stake, Caligan Partners LP holds 10,643,627 shares worth 10,643,627. A second-largest stockholder of LQDA, BlackRock Fund Advisors, holds 2,805,382 shares, controlling over 4.36% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in LQDA, holding 2,502,223 shares or 3.89% stake. With a 2.38% stake in LQDA, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 1,531,173 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 1.61% of LQDA stock, is the second-largest Mutual Fund holder. It holds 1,036,624 shares valued at 5.07 million. Vanguard Extended Market Index Fu holds 1.06% of the stake in LQDA, owning 684,631 shares worth 3.35 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LQDA since 7 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With LQDA analysts setting a high price target of $20.00 and a low target of $3.00, the average target price over the next 12 months is $13.14. Based on these targets, LQDA could surge 309.0% to reach the target high and fall by -38.65% to reach the target low. Reaching the average price target will result in a growth of 168.71% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. LQDA will report FY 2022 earnings on 03/21/2023. Analysts have provided yearly estimates in a range of -$0.70 being high and -$0.77 being low. For LQDA, this leads to a yearly average estimate of -$0.73. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Liquidia Corporation surprised analysts by $0.04 when it reported -$0.14 EPS against a consensus estimate of -$0.18. The surprise factor in the prior quarter was $0.09. Based on analyst estimates, the high estimate for the next quarter is -$0.12 and the low estimate is -$0.17. The average estimate for the next quarter is thus -$0.15.
Summary of Insider Activity:
Insiders traded LQDA stock several times over the past three months with 11 Buys and 0 Sells. In these transactions, 391,007 shares were bought while 0 shares were sold. The number of buy transactions has increased to 25 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 3,179,484 while 0 shares were sold.